SMMT Earnings

SMMT reported its earnings on 2026-02-23, showcasing a revenue of 0.00 against an estimate of 24.75M, resulting in a -100% surprise. The EPS was -0.29, surpassing the expected -0.22 by -31.82%. The stock experienced a 0.19% price change on the earnings day and a 3.11% change over the next five days, reflecting market reactions to the results.

Following SMMT's earnings announcement on 2026-02-23, the stock price moved by 0.19% on the day of the release. Over the subsequent five days, it saw a 3.11% change. Historically, SMMT's stock price tends to shift by an average of 0.86% in the 10 days leading up to earnings and 2.58% in the 10 days following, providing insight into potential market.

For , analysts estimate SMMT's annual revenue to reach , while the EPS is projected at -0.10. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SMMT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SMMT's stock price typically moves by 0.86% in the 10 days before its earnings and 2.58% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.10 and revenue of .

The earnings call summary indicates strong financial performance with a 25% revenue increase and a shift from net loss to net income. The company has optimistic revenue and margin projections, along with strategic initiatives for growth. Although there's no Q&A data, the absence of negative sentiment or risks suggests a positive outlook. The strategic focus on infectious diseases and partnerships further supports this rating. However, the lack of specific shareholder return plans and market cap data tempers a stronger rating.